沃森生物：关于冻干带状疱疹病毒mRNA疫苗临床试验申请获得受理的公告

Core Viewpoint - Watson Bio announced that its subsidiaries, in collaboration with Fudan University and Shanghai Blue Magpie Biopharmaceutical Co., have applied for clinical trials of a freeze-dried varicella-zoster virus mRNA vaccine, which has recently received an acceptance notice from the National Medical Products Administration [1] Group 1 - The application for clinical trials was made by Beijing Watson Innovation Biotechnology Co., Yunnan Vaccine Laboratory Co., and Yuxi Watson Biotechnology Co. [1] - The collaboration involves multiple entities, indicating a strategic partnership in vaccine development [1] - The acceptance notice from the regulatory authority marks a significant step forward in the vaccine's development process [1]